Notify me when Capitalink Ltd. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CMND | Clearmind Medicine Inc. | Common Shares, no par value per share | 10% | $2,093,139 | +$935,587 | 5,980,397 | +81% | Capitalink Ltd. | 03 Dec 2025 |
| N2OFF, Inc. | Common Stock, $0.0001 par value per share | 4.2% | 1,067,312 | -24% | Capitalink Ltd. | 15 May 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|